Physician profile
Rachael Piver
NPI 1386207611
$2,895.59
in general payments reported to CMS, 2019-2025
7 companies · $2,537 in 2025
The $2,537 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.37 · 2023: $18.09 · 2024: $294 · 2025: $2,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,282 · Education: $1,000 · Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,282.04 |
| Education | $1,000.00 |
| Food and Beverage | $567.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,233.83 | 2025 | Perclot, Floseal, Tisseel |
| Intuitive Surgical, INC. | $1,183.28 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $169.27 | 2022-2025 | Lynparza |
| Glaxosmithkline, LLC. | $164.38 | 2024 | Zejula |
| Merck Sharp & Dohme LLC | $88.59 | 2024-2025 | Keytruda, Lynparza |
| Medical Device Business Services, INC. | $40.46 | 2024 | Echelon Flex |
| Eisai INC. | $15.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachael Piver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.